| Dr James Carroll Boyd, MD | |
|
41680 Miss Bessie Dr, Suite 301, Leonardtown, MD 20650-2906 | |
| (301) 997-0055 | |
| (301) 997-0066 |
| Full Name | Dr James Carroll Boyd |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 50 Years |
| Location | 41680 Miss Bessie Dr, Leonardtown, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699883140 | NPI | - | NPPES |
| 252661100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | D19917 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Health Vna, Inc | Calverton, MD | Home health agency |
| Medstar Saint Mary's Hospital | Leonardtown, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
A new color-coding tool is enabling scientists to better track live blood stem cells over time, a key part of understanding how blood disorders and cancers like leukemia arise, report researchers in Boston Children's Hospital's Stem Cell Research Program.
Social and community disruptions caused by the COVID-19 restrictions could have a lasting effect on child wellbeing, Flinders University researchers warn.
AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.
A new study shows that a new 4-component meningococcal (4CMenB) vaccine for teenagers is effective when administered on a schedule of 2 doses from 1 to 6 months apart. María Elena Santolaya, from the Department of Pediatrics, University of Chile, Santiago, and colleagues performed the study, which was published online January 18 in the Lancet.
China BCT Pharmacy Group, Inc., a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced results for the first quarter ended March 31, 2010.
› Verified 5 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000347 |
News Archive
A new color-coding tool is enabling scientists to better track live blood stem cells over time, a key part of understanding how blood disorders and cancers like leukemia arise, report researchers in Boston Children's Hospital's Stem Cell Research Program.
Social and community disruptions caused by the COVID-19 restrictions could have a lasting effect on child wellbeing, Flinders University researchers warn.
AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.
A new study shows that a new 4-component meningococcal (4CMenB) vaccine for teenagers is effective when administered on a schedule of 2 doses from 1 to 6 months apart. María Elena Santolaya, from the Department of Pediatrics, University of Chile, Santiago, and colleagues performed the study, which was published online January 18 in the Lancet.
China BCT Pharmacy Group, Inc., a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced results for the first quarter ended March 31, 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Carroll Boyd, MD 41680 Miss Bessie Dr, Suite 301, Leonardtown, MD 20650-2906 Ph: (301) 997-0055 | Dr James Carroll Boyd, MD 41680 Miss Bessie Dr, Suite 301, Leonardtown, MD 20650-2906 Ph: (301) 997-0055 |
News Archive
A new color-coding tool is enabling scientists to better track live blood stem cells over time, a key part of understanding how blood disorders and cancers like leukemia arise, report researchers in Boston Children's Hospital's Stem Cell Research Program.
Social and community disruptions caused by the COVID-19 restrictions could have a lasting effect on child wellbeing, Flinders University researchers warn.
AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.
A new study shows that a new 4-component meningococcal (4CMenB) vaccine for teenagers is effective when administered on a schedule of 2 doses from 1 to 6 months apart. María Elena Santolaya, from the Department of Pediatrics, University of Chile, Santiago, and colleagues performed the study, which was published online January 18 in the Lancet.
China BCT Pharmacy Group, Inc., a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced results for the first quarter ended March 31, 2010.
› Verified 5 days ago
Dr. Jean Pierre El Khoury, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 25500 Point Lookout Rd, Leonardtown, MD 20650 Phone: 301-475-6119 | |
Dr. Dariush Liske-doorandish Ii, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 25500 Point Lookout Rd Dept Of, Leonardtown, MD 20650 Phone: 301-475-8981 | |
Umedchandra Shah, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 26840 Point Lookout Rd, Leonardtown, MD 20650 Phone: 301-475-5577 Fax: 301-884-7419 | |
Anand Nath, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 25500 Point Lookout Rd, Leonardtown, MD 20650 Phone: 301-475-8918 | |
Dr. Syed Kaleemullah Hussaini, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 25500 Point Lookout Rd, Leonardtown, MD 20650 Phone: 301-475-8981 | |
Mohammad Al-jundi, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 25500 Point Lookout Rd Dept Of, Leonardtown, MD 20650 Phone: 301-997-1250 | |
Rakhi Krishnan, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 26840 Point Lookout Rd, Leonardtown, MD 20650 Phone: 301-475-8885 Fax: 301-884-7419 |